Dr. med. Ken Kudura

Oberarzt Radiologie und Nuklearmedizin

Portrait Dr. med. Ken Kudura


  • Kudura K, Ritz N, Templeton AJ, Kutzker T, Hoffmann MHK, Antwi K, Zwahlen DR, Kreissl MC, Foerster R. An Innovative Non-Linear Prediction Model for Clinical Benefit in Women with Newly Diagnosed Breast Cancer Using Baseline FDG-PET/CT and Clinical Data. Cancers (Basel). 2023 Nov 20;15(22):5476. PMID: 38001736; PMCID: PMC10670812.
  • Hanke L, Tang H, Schröder C, Windisch P, Kudura K, Shelan M, Buchali A, Bodis S, Förster R, Zwahlen DR. Dose-Volume Histogram Parameters and Quality of Life in Patients with Prostate Cancer Treated with Surgery and High-Dose Volumetric-Intensity-Modulated Arc Therapy to the Prostate Bed. Cancers. 2023; 15(13):3454.
  • Kudura, K.; Ritz, N.; Templeton, A.J.; Kutzker, T.; Foerster, R.; Antwi, K.; Kreissl, M.C.; Hoffmann, M.H.K. Predictive Value of Total Metabolic Tumor Burden Prior to Treatment in NSCLC Patients Treated with Immune Checkpoint Inhibition. J. Clin. Med. 2023, 12, 3725.
  • Kudura, K.; Ritz, N.; Templeton, A.J.; Kissling, M.; Kutzker, T.; Foerster, R.; Hoffmann, M.H.K.; Antwi, K.; Kreissl, M.C. Additional Primary Tumors Detected Incidentally on FDG PET/CT at Staging in Patients with First Diagnosis of NSCLC: Frequency, Impact on Patient Management and Survival. Cancers 2023, 15, 1521. 
  • Kudura K, Ritz N, Kutzker T, Hoffmann MHK, Templeton AJ, Foerster R, Kreissl MC, Antwi K. Predictive Value of Baseline FDG-PET/CT for the Durable Response to Immune Checkpoint Inhibition in NSCLC Patients Using the Morphological and Metabolic Features of Primary Tumors. Cancers. 2022; 14(24):6095.
  • Antwi K, Caobelli F, Kudura K, Buchholz H-G, Hoffmann M, Schreckenberger M. Hypermetabolic Ipsilateral Supraclavicular and Axillary Lymphadenopathy: Optimal Time Point for Performing an 18F-FDG PET/CT after COVID-19 Vaccination. Diagnostics. 2022; 12(12):3073.
  • Gabryś H. S., Basler L., Burgermeister S., Hogan S., Ahmadsei M., Pavic M., M. Bogowicz, Vuong D., Tanadini-Lang S., Förster R., Kudura K., Huellner M., Dummer R., Levesque M.P. and Guckenberger M. PET/CT radiomics for prediction of hyperprogression in metastatic melanoma patients treated with immune checkpoint inhibitors. Front. Oncol., 2022,11.
  • Kudura K, Basler L, Nussbaumer L, Foerster R. Sex-Related Differences in Metastatic Melanoma Patients Treated with Immune Checkpoint Inhibition. Cancers. 2022; 14(20):5145.
  • Kudura K, Dimitriou F, Basler L, Förster R, Mihic-Probst D, Kutzker T, Dummer R, Mangana J, Burger IA, Kreissl MC. Correction: Kudura et al. Prediction of Early Response to Immune Checkpoint Inhibition Using FDG-PET/CT in Melanoma Patients. Cancers 2021, 13, 3830. Cancers (Basel). 2022 Jul 4;14(13):3268. doi: 10.3390/cancers14133268. Erratum for: Cancers (Basel). 2021 Jul 29;13(15): PMID: 35805065; PMCID: PMC9265328.
  • Kudura K, Nussbaumer L, Foerster R, Basler L. Inflammatory Blood Parameters as Biomarkers for Response to Immune Checkpoint Inhibition in Metastatic Melanoma Patients. Biomedicines. 2022 Aug 31;10(9):2135. doi: 10.3390/biomedicines10092135. PMID: 36140238; PMCID: PMC9496082.
  • Skawran, S.; Messerli, M.; Kotasidis, F.; Trinckauf, J.; Weyermann, C.; Kudura, K.; Ferraro, D.A.; Pitteloud, J.; Treyer, V.; Maurer, A.; et al. Can Dynamic Whole-Body FDG PET Imaging Differentiate between Malignant and Inflammatory Lesions? Life 2022, 12, 1350.
  • Kudura Ken, Kern Beatrice, Hoffmann Martin HK, Antwi Kwadwo: The use of 18F-Choline-PET/CT in chronic lymphocytic leukaemia. Journal of Clinical Images and Medical Case Reports. Mar 07, 2022
  • Husmann L, Huellner MW, Eberhard N, Ledergerber B, Kaelin MB, Anagnostopoulos A, Kudura K, Burger IA, Mestres CA, Rancic Z, Hasse B: PET/CT in therapy control of infective native aortic aneurysms. 2021: Sci Rep. 11(1): 5065.
  • Kudura K, Dimitriou F, Mihic-Probst D, Muehlematter UJ, Kutzker T, Basler L, Förster R, Dummer R, Mangana J, Husmann L, Burger IA, Kreissl MC: Malignancy Rate of Indeterminate Findings on FDG-PET/CT in Cutaneous Melanoma Patients. 2021: Diagnostics (Basel) 11 (5): 883.
  • Kudura K, Dimitriou F, Basler L, Förster R, Mihic-Probst D, Kutzker T, Dummer R, Mangana J, Burger IA, Kreissl MC: Prediction of Early Response to Immune Checkpoint Inhibition Using FDG-PET/CT in Melanoma Patients. 2021: Cancers (Basel) 13(15): 3830.
  • Liberini V, Messerli M, Husmann L, Kudura K, Grünig H, Maurer A, Skawran S, Orita E, Pizzuto DA, Deandreis D, Dummer R, Mangana J, Mihic-Probst D, Rupp N, Huellner MW: Improved detection of in-transit metastases of malignant melanoma with BSREM reconstruction in digital [18F]-FDG PET/CT. 2021: Eur Radiol. 10: 8011–8020.
  • Messerli M, Kotasidis F, Ferraro DA, Kudura K, Treyer V, Trinckauf J, Weyermann C, Hüllner M, Kaufmann P, Burger IA: Whole-body parametric [18F]-FDG PET/CT improves interpretation of a distant lesion as venous embolus in a lung cancer patient. 2021: Eur J Nucl Med Mol Imaging 48(6): 2047–2048.
  • Hilbers ML, Dimitriou F, Lau P, Bhave P, McArthur GA, Zimmer L, Kudura K, Gérard CL, Levesque MP, Michielin O, Dummer R, Cheng PF, Mangana J:Real-life data for first-line combination immune-checkpoint inhibition and targeted therapy in patients with melanoma brain metastases. 2021: Eur J Cancer 156: 149–163.
  • Ferraro DA, Lehner F, Becker AS, Kranzbühler B, Kudura K, Mebert I, Messerli M, Hermanns T, Eberli D, Burger IA: Improved oncological outcome after radical prostatectomy in patients staged with 68Ga-PSMA-11 PET: a single-center retrospective cohort comparison. 2021: Eur J Nucl Med Mol Imaging 48(4): 1219–1228.
  • Husmann L, Muehlematter UJ, Grimm F, Ledergerber B, Messerli M, Kudura K, Gruenig H, Muellhaupt B, Hasse B, Huellner MW: PET/CT helps to determine treatment duration in patients with resected as well as inoperable alveolar echinococcosis. 2021: Parasitol Int. 83: 102356.
  • Dimitriou F, Staeger R, Ak M, Maissen M, Kudura K, Barysch MJ, Levesque MP, Cheng PF, Dummer R, Mangana J: Frequency, Treatment and Outcome of Immune-Related Toxicities in Patients with Immune-Checkpoint Inhibitors for Advanced Melanoma: Results from an Institutional Database Analysis. 2021: Cancers (Basel) 13(12): 2931
  • Gebhard, Catherine, Michael Messerli, Christine Lohmann, Valerie Treyer, Susan Bengs, Dominik C. Benz, Andreas A. Giannopoulos, u. a. „Sex and Age Differences in the Association of Heart Rate Responses to Adenosine and Myocardial Ischemia in Patients Undergoing Myocardial Perfusion Imaging“. Journal of Nuclear Cardiology: Official Publication of the American Society of Nuclear Cardiology 27, Nr. 1 (Februar 2020): 159–70.
  • Grossmann, Marvin, Andreas A. Giannopoulos, Fabiola A. Bechtiger, Michael Messerli, Moritz Schwyzer, Dominik C. Benz, Ken Kudura, u. a. „Ultra-Low-Dose Computed Tomography for Attenuation Correction of Cadmium-Zinc-Telluride Single Photon Emission Computed Tomography Myocardial Perfusion Imaging“. Journal of Nuclear Cardiology: Official Publication of the American Society of Nuclear Cardiology 27, Nr. 1 (Februar 2020): 228–37.
  • Kudura, Ken, Tobias Oblasser, Daniela A. Ferraro, Caecilia E. Mader, Lars Husmann, Kerstin Friedrich, Edwin E. G. W. Ter Voert, und Irene A. Burger. „Metal Artifact Reduction in 68Ga-PSMA-11 PET/MRI for Prostate Cancer Patients with Hip Joint Replacement Using Multiacquisition Variable-Resonance Image Combination“. European Journal of Hybrid Imaging 4, Nr. 1 (9. April 2020): 6.
  • Rüegg, Pascal, Grégoire B. Morand, Ken Kudura, Niels J. Rupp, Martin W. Hüllner, und Martina A. Broglie. „Tumor Cell Viability in Salvage Neck Dissections: Poor Prognosis Predicted by High Postradiation Nodal SUVmax , P16-Negativity, and Low Nodal Shrinkage“. Head & Neck 42, Nr. 4 (April 2020): 660–69.
  • Schwyzer, Moritz, Katharina Martini, Dominik C. Benz, Irene A. Burger, Daniela A. Ferraro, Ken Kudura, Valerie Treyer, u. a. „Artificial Intelligence for Detecting Small FDG-Positive Lung Nodules in Digital PET/CT: Impact of Image Reconstructions on Diagnostic Performance“. European Radiology 30, Nr. 4 (April 2020): 2031–40.
  • Svirydenka, Hanna, Urs J. Muehlematter, Hannes W. Nagel, Gaspar Delso, Daniela A. Ferraro, Ken Kudura, Irene A. Burger, und Edwin E. G. W. Ter Voert. „68Ga-PSMA-11 Dose Reduction for Dedicated Pelvic Imaging with Simultaneous PET/MR Using TOF BSREM Reconstructions“. European Radiology 30, Nr. 6 (Juni 2020): 3188–97.
  • Husmann, Lars, Martin W. Huellner, Bruno Ledergerber, Nadia Eberhard, Marisa B. Kaelin, Alexia Anagnostopoulos, Ken Kudura, u. a. „Diagnostic Accuracy of PET/CT and Contrast Enhanced CT in Patients With Suspected Infected Aortic Aneurysms“. European Journal of Vascular and Endovascular Surgery: The Official Journal of the European Society for Vascular Surgery 59, Nr. 6 (Juni 2020): 972–81.
  • Haider, Ahmed, Susan Bengs, Katharina Schade, Winandus J. Wijnen, Angela Portmann, Dominik Etter, Sandro Fröhlich, u. a. „Myocardial 18F-FDG Uptake Pattern for Cardiovascular Risk Stratification in Patients Undergoing Oncologic PET/CT“. Journal of Clinical Medicine 9, Nr. 7 (17. Juli 2020): E2279.
  • Basler, Lucas, Hubert S. Gabryś, Sabrina A. Hogan, Matea Pavic, Marta Bogowicz, Diem Vuong, Stephanie Tanadini-Lang, u. a. „Radiomics, Tumor Volume, and Blood Biomarkers for Early Prediction of Pseudoprogression in Patients with Metastatic Melanoma Treated with Immune Checkpoint Inhibition“. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 26, Nr. 16 (15. August 2020): 4414–25.
  • Mihic-Probst, Daniela, Michael Reinehr, Susanne Dettwiler, Isabel Kolm, Christian Britschgi, Ken Kudura, Ewerton Marques Maggio, Daniela Lenggenhager, und Elisabeth J. Rushing. „The Role of Macrophages Type 2 and T-Regs in Immune Checkpoint Inhibitor Related Adverse Events“. Immunobiology 225, Nr. 5 (September 2020): 152009.
  • Benz, Dominik C., Georgios Benetos, Georgios Rampidis, Elia von Felten, Adam Bakula, Aleksandra Sustar, Ken Kudura, u. a. „Validation of Deep-Learning Image Reconstruction for Coronary Computed Tomography Angiography: Impact on Noise, Image Quality and Diagnostic Accuracy“. Journal of Cardiovascular Computed Tomography 14, Nr. 5 (Oktober 2020): 444–51.
  • Messerli, Michael, Monika Maredziak, Susan Bengs, Ahmed Haider, Andreas A. Giannopoulos, Moritz Schwyzer, Dominik C. Benz, u. a. „Association between Beta-Adrenoceptor Antagonist-Induced Sympathicolysis and Severity of Coronary Artery Disease as Assessed by Coronary Computed Tomography Angiography (CCTA)“. The International Journal of Cardiovascular Imaging 35, Nr. 5 (Mai 2019): 927–36.
  • Gebhard, Caroline E., Monika Marędziak, Angela Portmann, Susan Bengs, Ahmed Haider, Michael Fiechter, Bernhard A. Herzog, u. a. „Heart Rate Reserve Is a Long-Term Risk Predictor in Women Undergoing Myocardial Perfusion Imaging“. European Journal of Nuclear Medicine and Molecular Imaging 46, Nr. 10 (September 2019): 2032–41.
  • Fiechter, Michael, Andrea Roggo, Ahmed Haider, Susan Bengs, Irene A. Burger, Monika Marędziak, Angela Portmann, u. a. „Metabolic Activity in Central Neural Structures of Patients With Myocardial Injury“. Journal of the American Heart Association 8, Nr. 19 (Oktober 2019): e013070.
  • Nordmann, Thierry M., Olivia Messerli-Odermatt, Larissa Meier, Sara Micaletto, Thomas Coppetti, Mirjam Nägeli, Jivko Kamarachev, u. a. „Sequential Somatic Mutations upon Secondary Anti-HER2 Treatment Resistance in Metastatic ERBB2S310F Mutated Extramammary Paget’s Disease“. Oncotarget 10, Nr. 62 (19. November 2019): 6647–50.
  • Burger, Irene A., Christine Lohmann, Michael Messerli, Susan Bengs, Anton Becker, Monika Maredziak, Valerie Treyer, u. a. „Age- and Sex-Dependent Changes in Sympathetic Activity of the Left Ventricular Apex Assessed by 18F-DOPA PET Imaging“. PloS One 13, Nr. 8 (2018): e0202302.
  • Morand, Grégoire B., Domenic G. Vital, Ken Kudura, Jonas Werner, Sandro J. Stoeckli, Gerhard F. Huber, und Martin W. Huellner. „Maximum Standardized Uptake Value (SUVmax) of Primary Tumor Predicts Occult Neck Metastasis in Oral Cancer“. Scientific Reports 8, Nr. 1 (7. August 2018): 11817.

Kontakt Claraspital
Unsere Telefonzeiten sind Montag bis Freitag von 08.00–17.00 Uhr. Ausserhalb der Telefonzeiten ist die Rezeption rund um die Uhr besetzt.

T +41 61 685 85 85

Alle Telefonnummern
Besuchszeiten & Anreise